DAVIDSON INVESTMENT ADVISORS - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 915 filers reported holding BAXTER INTL INC in Q4 2013. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
DAVIDSON INVESTMENT ADVISORS ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2020$219,000
-3.1%
2,6990.0%0.03%
+27.3%
Q4 2019$226,000
-4.2%
2,6990.0%0.02%
-12.0%
Q3 2019$236,000
-37.4%
2,699
-44.9%
0.02%
-32.4%
Q3 2018$377,000
-96.3%
4,896
-96.5%
0.04%
-96.6%
Q2 2018$10,282,000
+13.5%
139,245
-0.1%
1.08%
+10.6%
Q1 2018$9,063,000
-2.4%
139,349
-3.0%
0.98%
+1.2%
Q4 2017$9,285,000
+3.9%
143,641
+0.9%
0.96%
-0.1%
Q3 2017$8,934,000
+22.4%
142,386
+18.1%
0.96%
-6.3%
Q2 2017$7,298,000
+3.3%
120,575
-11.5%
1.03%
+12.9%
Q1 2017$7,063,000
+28.2%
136,245
+9.6%
0.91%
+16.2%
Q4 2016$5,510,000
+61.8%
124,320
+73.7%
0.78%
+50.7%
Q3 2016$3,405,000
+9.6%
71,590
+4.1%
0.52%0.0%
Q2 2016$3,107,000
-33.8%
68,757
-39.9%
0.52%
-34.4%
Q1 2016$4,694,000
+15.5%
114,315
+7.2%
0.79%
+17.5%
Q4 2015$4,065,000
+20.6%
106,610
+3.8%
0.68%
+10.8%
Q3 2015$3,371,000
-58.8%
102,700
-12.2%
0.61%
-50.4%
Q2 2015$8,181,000
+0.1%
117,027
-1.9%
1.23%
+0.6%
Q1 2015$8,173,000
-7.6%
119,337
-1.2%
1.22%
-7.8%
Q4 2014$8,847,000
-44.3%
120,737
-47.6%
1.33%
+5.7%
Q3 2014$15,890,000
+82.4%
230,633
+91.3%
1.26%
-1.2%
Q2 2014$8,714,000
-2.9%
120,568
-1.1%
1.27%
-6.5%
Q1 2014$8,972,000
+6.3%
121,968
+0.5%
1.36%
+5.6%
Q4 2013$8,442,000
+18.9%
121,413
+12.3%
1.29%
+12.6%
Q3 2013$7,100,000
-5.8%
108,124
-0.6%
1.14%
-9.2%
Q2 2013$7,535,000108,8141.26%
Other shareholders
BAXTER INTL INC shareholders Q4 2013
NameSharesValueWeighting ↓
Third Point 36,000,000$2,658,240,00018.52%
SECTOR GAMMA AS 721,058$53,243,0008.85%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,747,061$202,843,0005.38%
Veritas Asset Management LLP 8,852,005$653,632,0005.36%
Knowledge Leaders Capital, LLC 79,384$5,862,0004.39%
HealthCor Management, L.P. 1,800,000$132,912,0004.22%
Progressive Investment Management Corp 79,282$5,854,0003.78%
13D Management LLC 200,318$14,791,0003.77%
ARGENT CAPITAL MANAGEMENT LLC 1,288,236$95,123,0003.42%
Chiron Investment Management, LLC 612,787$45,248,0003.12%
View complete list of BAXTER INTL INC shareholders